Novak D - Search Results

1

Cellular Reprogramming-A Model for Melanoma Cellular Plasticity.

Granados K, Poelchen J, Novak D, Utikal J. Granados K, et al. Among authors: novak d. Int J Mol Sci. 2020 Nov 5;21(21):8274. doi: 10.3390/ijms21218274. Int J Mol Sci. 2020. PMID: 33167306 Free PMC article. Review.

2

Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells.

Knappe N, Novak D, Weina K, Bernhardt M, Reith M, Larribere L, Hölzel M, Tüting T, Gebhardt C, Umansky V, Utikal J. Knappe N, et al. Among authors: novak d. Stem Cells. 2016 Apr;34(4):832-46. doi: 10.1002/stem.2284. Epub 2016 Jan 19. Stem Cells. 2016. PMID: 26753613

3

SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma.

Hüser L, Sachindra S, Granados K, Federico A, Larribère L, Novak D, Umansky V, Altevogt P, Utikal J. Hüser L, et al. Among authors: novak d. Int J Cancer. 2018 Dec 15;143(12):3131-3142. doi: 10.1002/ijc.31609. Epub 2018 Oct 16. Int J Cancer. 2018. PMID: 29905375 Free article.

4

Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulation.

Wu H, Larribère L, Sun Q, Novak D, Sachindra S, Granados K, Umansky V, Utikal J. Wu H, et al. Among authors: novak d. Int J Cancer. 2018 Dec 1;143(11):2962-2972. doi: 10.1002/ijc.31799. Epub 2018 Sep 29. Int J Cancer. 2018. PMID: 30110134 Free article.

5

Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.

Orouji E, Federico A, Larribère L, Novak D, Lipka DB, Assenov Y, Sachindra S, Hüser L, Granados K, Gebhardt C, Plass C, Umansky V, Utikal J. Orouji E, et al. Among authors: novak d. Int J Cancer. 2019 Dec 15;145(12):3462-3477. doi: 10.1002/ijc.32432. Epub 2019 Jun 9. Int J Cancer. 2019. PMID: 31131878 Free article.

6

FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor.

Sun Q, Novak D, Hüser L, Poelchen J, Wu H, Granados K, Federico A, Liu K, Steinfass T, Vierthaler M, Umansky V, Utikal J. Sun Q, et al. Among authors: novak d. Int J Cancer. 2021 Aug 1;149(3):657-674. doi: 10.1002/ijc.33591. Epub 2021 May 6. Int J Cancer. 2021. PMID: 33837564 Free article.

7

Melanoma Cellular Plasticity.

Novak D, Utikal J. Novak D, et al. Int J Mol Sci. 2022 Jun 8;23(12):6401. doi: 10.3390/ijms23126401. Int J Mol Sci. 2022. PMID: 35742846 Free PMC article.

8

Mediators of induced pluripotency and their role in cancer cells - current scientific knowledge and future perspectives.

Bernhardt M, Galach M, Novak D, Utikal J. Bernhardt M, et al. Among authors: novak d. Biotechnol J. 2012 Jun;7(6):810-21. doi: 10.1002/biot.201100347. Epub 2012 May 16. Biotechnol J. 2012. PMID: 22589234 Review.

9

From skin to other cell types of the body.

Novak D, Weina K, Utikal J. Novak D, et al. J Dtsch Dermatol Ges. 2014 Sep;12(9):789-92. doi: 10.1111/ddg.12403. Epub 2014 Aug 1. J Dtsch Dermatol Ges. 2014. PMID: 25087921 Free article. Review.

10

NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model.

Larribere L, Wu H, Novak D, Galach M, Bernhardt M, Orouji E, Weina K, Knappe N, Sachpekidis C, Umansky L, Beckhove P, Umansky V, De Schepper S, Kaufmann D, Ballotti R, Bertolotto C, Utikal J. Larribere L, et al. Among authors: novak d. Pigment Cell Melanoma Res. 2015 Jul;28(4):407-16. doi: 10.1111/pcmr.12369. Epub 2015 Apr 22. Pigment Cell Melanoma Res. 2015. PMID: 25824590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

550 results

Search Page